Eris Pharmaceuticals Limited

Founded in 2020 and headquartered in Uttar Pradesh, India.

2020 | Kanpur Nagar, Uttar Pradesh (India) | Active
Last Updated:

Eris Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth %
  • Profit Growth -375.00%
  • Ebitda -500.00%
  • Net Worth -1900.00%
  • Total Assets -70.83%

About Eris Pharmaceuticals

Eris Pharmaceuticals Limited (EPL) is a Public Limited Indian Non-Government Company incorporated in India on 02 June 2020 (Four years and 11 months 10 days old ). Its registered office is in Kanpur Nagar, Uttar Pradesh, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Kaushal Shah, Inderjeet Negi, and Sachin Shah serve as directors at the Company.

Company Details

  • Location

    Kanpur Nagar, Uttar Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U33100UP2020PLC128964

  • Company No.

    128964

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    02 Jun 2020

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Kanpur

Industry

Pharma
Company report

Eris Pharmaceuticals Limited

Explore comprehensive data for Eris Pharmaceuticals Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Eris Pharmaceuticals?

Board Members (3)

NameDesignationAppointment DateStatus
Kaushal Shah Country flag representing In Director 30-Jul-2024Current
Inderjeet Negi Country flag representing In Director 30-Jul-2024Current
Sachin Shah Country flag representing In Director 30-Jul-2024Current

Financial Performance of Eris Pharmaceuticals.

Eris Pharmaceuticals Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 375% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1900%.

Eris Pharmaceuticals revenue growth over time
Eris Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-70.83%
Profit or Loss
-375.00%
Net Worth
-1900.00%
EBITDA
-500.00%

What is the Ownership and Shareholding Structure of Eris Pharmaceuticals?

In 2023, Eris Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Eris Pharmaceuticals?

Eris Pharmaceuticals has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Eris Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eris Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eris Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Eris Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Eris Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Director Appointment

    Kaushal Kamlesh Shah was appointed as a Director was appointed as a Director on 30 Jul 2024 & has been associated with this company since 9 months 13 days .

  • Director Appointment

    Inderjeet Singh Negi was appointed as a Director was appointed as a Director on 30 Jul 2024 & has been associated with this company since 9 months 13 days .

  • Director Appointment

    Sachin Shah was appointed as a Director was appointed as a Director on 30 Jul 2024 & has been associated with this company since 9 months 13 days .

  • Balance Sheet

    Eris Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.

  • Company Incorporation

    Eris Pharmaceuticals Limited was registered on 02 Jun 2020 with Roc Kanpur & aged 4 years 11 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Eris Pharmaceuticals Limited?

    Eris Pharmaceuticals Limited was incorporated on 02 Jun 2020.

  • What is authorized share capital and paid-up capital of Eris Pharmaceuticals Limited?

    The authorized share capital of Eris Pharmaceuticals Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Eris Pharmaceuticals Limited?

    Currently 3 directors are associated with Eris Pharmaceuticals Limited.

    • Kaushal Kamlesh Shah
    • Inderjeet Singh Negi
    • Sachin Shah

  • What is the registered address of Eris Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Eris Pharmaceuticals Limited is Arazi No. 1554 Vill Sachendi, Kalpi Road India, Fatehpur Roshnai, Uttar Pradesh, 209304.

  • What is the corporate identification number (CIN) and company number of Eris Pharmaceuticals Limited?

    The corporate identification number (CIN) of Eris Pharmaceuticals Limited is U33100UP2020PLC128964 and the company number is 128964 as per Ministry of Corporate Affairs (MCA).

  • What change has been observed in the net worth of Eris Pharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Eris Pharmaceuticals Limited has experienced an downturn of -1900.00%.

  • When was the last Balance Sheet of Eris Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Eris Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development